Han Liang's Research Group
AI, Big data, Cancer, Drug development
Representative peer-reviewed publications
-
A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependenciesNature Cancer in press [PDF]
-
Neoadjuvant PARPi or Chemotherapy in Ovarian Cancer Informs Targeting Effector Treg Cells for Homologous-Recombination-Deficient TumorsCell in press [PDF]
-
Tumor-intrinsic SIRPA Promotes Sensitivity to Checkpoint Inhibition Immunotherapy in MelanomaCancer Cell 40(11):1324-1340 [PDF]
-
Next-generation analystics for omics dataCancer Cell 39(1): 3-6 [PDF]
-
Large-scale characterization of drug responses of clinically relevant proteins in cancer cell linesCancer Cell 38(6): 829-843 [PDF]
-
A high-resolution map of human enhancer RNA loci characterizes super-enhancer activities in cancerCancer Cell 38(5): 701-715 [PDF]
-
Comprehensive Molecular Characterization of Mitochondrial Genomes in Human CancersNature Genetics 52 (3): 342-352 [PDF]
-
A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient SamplesCell 173(2):386-399 [PDF]
-
Characterization of human cancer cell lines by reverse phase protein arraysCancer Cell 31(2): 225-239 [PDF]
-
Comprehensive characterization of molecular differences in cancer between male and female patientsCancer Cell 29(5): 711-722 [PDF]
-
The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers
-
Assessing the clinical utility of cancer genomic and proteomic data across tumor typesNature Biotechnology 32 (7): 644-52 [PDF]